Tenet Healthcare Corporation

NYQ: THC
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Tenet Healthcare Corporation's price action across multiple timeframes using regression channels and statistical scoring.

Get THC Z-Score →

About Tenet Healthcare Corporation

Healthcare Medical Care Facilities
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

📊 Fundamental Analysis

Tenet Healthcare Corporation demonstrates a profit margin of 6.6%, which is below the sector average, suggesting competitive pressure.

The company recently reported 8.9% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is 27.0%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $195.24, THC currently sits at the 62nd percentile of its 52-week range (Range: $109.82 - $247.21).

💰 Valuation Insight

THC trades at a 49.6% discount (PE: 12.61), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
⚠️ Revenue Growth Moderate
Return on Equity Excellent
🔴 Beta (Risk) High Volatility

Key Financials

Market Cap
$17.16B
Trailing P/E
12.61
Forward P/E
11.12
Beta (5Y)
1.50
52W High
$247.21
52W Low
$109.82
Avg Volume
1.08M
Day High
Day Low
Get THC Z-Score on Dashboard 🚀